Please select your Region.
Please select your Region.
Apr 17, 2014
ARKRAY, Inc. (herein 'ARKRAY') has established a sales office ARKRAY Co. Ltd., Inc. in Muntinlupa City, the Philippines. Sales and marketing operations are due to begin there from this May. The establishment of this office is part of ARKRAY's strategy to expand its business in South East Asia.
GDP in the Philippines increased 6.8%*1 in FY2013 and continues to show strong growth. Its in vitro diagnostic market is currently valued at 4.6 billion yen*2. With a population nearing 100 million, its diabetic population has reached a peak of 5.42 million which is expected to grow to 7 million by 2030*3.
ARKRAY Co. Ltd., Inc. will begin sales of diabetic test instruments and compatible reagents from May 2014 to meet this increased need for medical devices and in vitro diagnostics.
Indonesia is another country with strong growth. Sales are due to begin from the established sales office there PT.ARKRAY in May this year. Indonesia has the largest population within ASEAN (at about 240 million) and has an in vitro diagnostic market valued at approximately 7.9 billion yen*2. Indonesia is either the largest or second largest market within ASEAN. These markets are expected to continue to grow in line with overall economic growth. ARKRAY aims to boost growth through this increase in sales power as well as through an expanded product lineup as evidenced by the recent acquisition of the Indian company Span Diagnostics Ltd.
Starting with Indonesia and the Philippines, ARKRAY is focused on aggressive business expansion in the South East Asian region and meeting customer needs in all regions. ARKRAY has now estblished offices in 11 countries world wide and does business in more than 80. ARKRAY will continue to expand its business centers and work to increase its sales muscle.
*1 Survey by Philippine National Statistical Coordination Board (NSCB)
*2 Survey by Frost & Sullivan (FY2011)
*3 Survey by the International Diabetes Federation (FY2012)
Company name | ARKRAY Co. Ltd., Inc. |
---|---|
Location | Unit 1912 Entrata Tower, Civic Drive, Filinvest Corporate Center, Muntinlupa City 1781, PHILIPPINES Tel: +63-2-843-4731 |
Start of business | May 2014 |
Nature of business | Sales of and customer service for clinical test instruments and in vitro diagnostic reagents |
We use (i) Necessary cookies to provide you with services on the website, (ii) Functional cookies to ensure the proper functioning of browsing, (iii) Analytical cookies to collect information to analyze the traffic to the website and (iv) Performance cookies to count visits and traffic sources in order to improve website performance.
You can inhibit Functional cookies and/or both Analytical and Performance cookies by clicking on OPTIONS.
By clicking ACCEPT, it will be deemed that you accept all the mentioned types of cookies.
When you visit our website, we use the following cookies for a variety of purposes and to enhance your online experience on our website. You can change your preferences and accept/decline certain types of cookies that would otherwise be stored on your computer while browsing our website by adding/removing check marks. But keep in mind that deleting cookies may have an impact on your experience with our website.